The mission of the TIA-QLD Node is to provide a facilitated pathway to assist Australian life sciences discovery researchers to progress their inventions through the various nonclinical & clinical development steps to the point where they will attract investment for commercialization into products for improving human health.

For more information please visit the Therapeutic Innovation Website

Read more information on TIA-QLD Node

TetraQ is an experienced commercial and regulatory compliant preclinical and clinical contract research organisation (GLP/ISO17025) located in a university research centre. TetraQ's broad range of high quality integrated preclinical and clinical testing and R&D services is backed up by in-depth technical-scientific expertise and experience in drug development and translational research, which sets it apart from so many other CROs.

Read more information on TetraQ

The National Collaborative Research Infrastructure Strategy drives research excellence and collaboration between 35,000 researchers, government and industry to deliver practical outcomes.

Read more

CIPDD’s GLP recognition by the National Association of Testing Authorities (NATA) means that date from our in vivo toxicology studies undertaken in support of the TetraQ RIC will be accepted for review when included in submissions to international regulatory agencies.

 

Read more